Desjardins Global Asset Management’s ResMed RMD Stock Holding History

Desjardins Global Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$101K	Buy	585 +109	+23%	+$16.7K	0.01%	470
2023 Q3	$70.4K	Sell	476 -2,699	-85%	-$488K	0.01%	508
2023 Q2	$694K	Buy	3,175 +594	+23%	+$132K	0.08%	239
2023 Q1	$565K	Buy	2,581 +264	+11%	+$57.3K	0.07%	225
2022 Q4	$482K	Buy	2,317 +117	+5%	+$25.7K	0.08%	221
2022 Q3	$480K	Sell	2,200 -7	-0.3%	-$1.59K	0.06%	232
2022 Q2	$462K	Buy	2,207 +131	+6%	+$27.9K	0.06%	237
2022 Q1	$503K	Buy	2,076 +1	+0%	+$242	0.04%	261
2021 Q4	$540K	Buy	+2,075	New	+$538K	0.05%	269

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Desjardins Global Asset Management's RMD Position: Q4 2023 in Review

Desjardins Global Asset Management increased its ResMed (RMD) stake by 23% in Q4 2023, buying an estimated $16.7K and bringing the position to 585 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #470.

Desjardins Global Asset Management first reported a position in RMD in Q4 2021 and has held it in 9 quarters since. The position peaked at $694K in Q2 2023. 687 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Desjardins Global Asset Management held 585 shares of ResMed worth $101K as of Q4 2023.
Desjardins Global Asset Management bought 109 ResMed shares in Q4 2023, an estimated $16.7K.
ResMed made up 0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #470 holding.
Desjardins Global Asset Management first reported a position in ResMed in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's ResMed position peaked at $694K in Q2 2023.
687 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.